Cargando…
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma
To determine the outcome of patients with metastatic malignant melanoma (MMM) treated with palliative whole brain radiotherapy (WBRT) and to identify factors that predict treatment outcome to assist future trial design, a retrospective study was performed on patients with MMM who received WBRT at th...
Autores principales: | Morris, S L, Low, S H, A'Hern, R P, Eisen, T G, Gore, M E, Nutting, C M, Harrington, K J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409881/ https://www.ncbi.nlm.nih.gov/pubmed/15305201 http://dx.doi.org/10.1038/sj.bjc.6602018 |
Ejemplares similares
-
Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
por: Kirby, A M, et al.
Publicado: (2006) -
Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
por: Waters, J S, et al.
Publicado: (2004) -
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.
por: Ahmed, F. Y., et al.
Publicado: (1996) -
Effective palliative radiotherapy in primary malignant melanoma of the esophagus: a case report
por: Nonoshita, Takeshi, et al.
Publicado: (2009) -
Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era
por: Youland, Ryan S., et al.
Publicado: (2017)